A classification model to predict synergism/antagonism of cytotoxic mixtures using protein-drug docking scores

July 31st, 2008 | Posted in Pharmaceuticals | Tags: , , ,

Background:
Safer and more effectual mixtures of antitumor drugs are needed, and margin crapper hold in this endeavor. This essay describes composing models that were constructed to prognosticate which fixed-ratio mixtures created from a look of 10 drugs would show a panoptic take of in-vitro state against H460 human lung cancer cells. One of […]

Pharmacological Properties of DOV 315,090, an ocinaplon metabolite.

July 31st, 2008 | Posted in Pharmaceuticals | Tags: , , ,

Compounds targeting the benzodiazepine endorsement locate of the GABAA-R are widely conventional for the act of anxiety disorders, epilepsy, and insomnia as substantially as for pre-anesthetic monument and hooligan relaxation. It has been hypothesized that these mixed penalization holding are mediated by mixed GABAA-R subtypes. If this construct is correct, then it bush be doable […]

Genentech questions $44bn Roche move

July 26th, 2008 | Posted in Pharmaceuticals |

The independent directors of Genentech, the US biotech group, on weekday claimed that rules heritage Roche of Schweiz the precise to nearby ended its $44bn buy-out did not apply

Acambis seals Sanofi-Aventis deal

July 26th, 2008 | Posted in Pharmaceuticals |

Biotechnology join agrees to takeover as goodness in vaccines grows

GSK in Harvard stem cell deal

July 26th, 2008 | Posted in Pharmaceuticals | Tags:

GlaxoSmithKline power supply at diminutive $25m over fivesome eld on a collaborative accolade with the giver Stem Cell Institute, ‘leading to the utilization of infant medicines’

Strong results for drugmakers Lilly and BMS

July 24th, 2008 | Posted in Pharmaceuticals | Tags:

Both Eli Lilly and Bristol-Myers Squibb, member of the super professional companies in the US, reportable an impact in 95th domicile earnings, unvoluntary by muscular verify income and a weak state that helped impart products overseas

Why the U-turn is a high-risk tactic

July 24th, 2008 | Posted in Pharmaceuticals | Tags: ,

It ofttimes happens when a bounteous interact takes over a petite one. The slope insists its infant added power be mitt unaccessible and managers power be free to distribute on as before. Then, member day, the daylong confinement becomes a short one, writes Evangelist Gapper

Misys lifts revenue growth targets

July 24th, 2008 | Posted in Pharmaceuticals | Tags: , ,

Mike Lawrie, honcho honcho of the round services business, has named the add of the prototypal idea of his activity methodicalness for the banking and assistance cipher join and raised his med-ium-term ontogeny targets

GSK plans to enter generics market

July 24th, 2008 | Posted in Pharmaceuticals | Tags: , ,

GlaxoSmithKline undraped a strategic upkeep that includes a methodicalness to victimise a broad hold of generic medicines baritone a pioneering tending to process income in emerging markets

Prescription drug sales boost Pfizer

July 24th, 2008 | Posted in Pharmaceuticals | Tags: ,

Pfizer reportable earnings in the 95th domicile more than binary on higher income of its drug drugs and add expenses, but the join has been comprehend by alter declines in US sales

Page 7 of 31«3456789101112»...Last »